The same day I wrote that capitalism was coming apart at the seams, indicated by the shocking disparity between the compensation of corporate CEOs and workers, the Business Roundtable published its new statement of purpose of a corporation.* The 180 or so corporate executives who signed the statement declared that all their stakeholders, not just owners of equity shares, were important to their mission. Many business pundits, such as Andrew Ross Sorkin, greeted the new statement as a sign...
Read More »Is the Financialization Hypothesis a Theoretical Blind Alley? – World Review of Political Economy
World Review of Political Economy Vol. 9, No. 4, Journal Article Is the Financialization Hypothesis a Theoretical Blind Alley? Stavros Mavroudeas and Demophanes Papadatos World Review of Political Economy Vol. 9, No. 4 (Winter 2018), pp. 451-476 Published by: Pluto Journals DOI: 10.13169/worlrevipoliecon.9.4.0451 https://www.jstor.org/stable/10.13169/worlrevipoliecon.9.4.0451 Page Count: 26...
Read More »The Week — Pharmaceutical company CEO says he has a ‘moral requirement’ to sell drugs at the highest price
Because "shareholder value." [Nirmal Mulye, chief executive of Nostrum Laboratories,] told FT he agreed with Martin "Pharma Bro" Shkreli raising the price of AIDS and cancer drug Daraprim in 2015 from $13.50 to $750 per tablet, saying he was "within his rights because he had to reward his shareholders." We live in a "capitalist economy and if you can't make money you can't stay in business," Mulye said. "We have to make money when we can. Appropriately, nirman means "no mind."The Week...
Read More »